1. Home
  2. SPFI vs CBLL Comparison

SPFI vs CBLL Comparison

Compare SPFI & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo South Plains Financial Inc.

SPFI

South Plains Financial Inc.

HOLD

Current Price

$44.42

Market Cap

794.2M

Sector

Finance

ML Signal

HOLD

Logo CeriBell Inc.

CBLL

CeriBell Inc.

HOLD

Current Price

$17.87

Market Cap

726.2M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPFI
CBLL
Founded
1941
2014
Country
United States
United States
Employees
N/A
300
Industry
Major Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
794.2M
726.2M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
SPFI
CBLL
Price
$44.42
$17.87
Analyst Decision
Buy
Strong Buy
Analyst Count
3
5
Target Price
$46.00
$23.20
AVG Volume (30 Days)
150.0K
342.5K
Earning Date
04-28-2026
05-11-2026
Dividend Yield
1.68%
N/A
EPS Growth
17.81
N/A
EPS
0.85
N/A
Revenue
N/A
N/A
Revenue This Year
$22.65
$29.57
Revenue Next Year
$9.40
$28.44
P/E Ratio
$52.51
N/A
Revenue Growth
N/A
N/A
52 Week Low
$35.34
$10.85
52 Week High
$46.94
$24.33

Technical Indicators

Market Signals
Indicator
SPFI
CBLL
Relative Strength Index (RSI) 58.76 44.40
Support Level $39.06 $17.10
Resistance Level $46.94 $19.35
Average True Range (ATR) 1.34 0.76
MACD 0.09 -0.27
Stochastic Oscillator 58.19 42.99

Price Performance

Historical Comparison
SPFI
CBLL

About SPFI South Plains Financial Inc.

South Plains Financial Inc operates as a bank holding company. The company provides a wide range of commercial and consumer financial services to small and medium-sized businesses and individuals. The principal business activities include commercial and retail banking, along with insurance, investment, trust, and mortgage services. The company has one reportable segment: banking. The majority of the company's revenues is derived from interest income and other sources, including loans, securities and derivatives.

About CBLL CeriBell Inc.

CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.

Share on Social Networks: